Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Perampanel (Fycompa): A Review of Clinical Efficacy and Safety in Epilepsy.

Literature DB >> 27904300

Perampanel (Fycompa): A Review of Clinical Efficacy and Safety in Epilepsy.

Jessica Greenwood, Jose Valdes.

Abstract

Perampanel (Fycompa): a review of clinical efficacy and safety in epilepsy.

Entities: Chemical Disease

Year: 2016 PMID： 27904300 PMCID： PMC5083075

Source DB: PubMed Journal: P T ISSN： 1052-1372

15 in total

1. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.

Authors: G L Krauss; J M Serratosa; V Villanueva; M Endziniene; Z Hong; J French; H Yang; D Squillacote; H B Edwards; J Zhu; A Laurenza
Journal: Neurology Date: 2012-04-18 Impact factor: 9.910

2. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.

Authors: Jacqueline A French; Gregory L Krauss; Victor Biton; David Squillacote; Haichen Yang; Antonio Laurenza; Dinesh Kumar; Michael A Rogawski
Journal: Neurology Date: 2012-07-25 Impact factor: 9.910

3. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.

Authors: Gregory L Krauss; Emilio Perucca; Elinor Ben-Menachem; Patrick Kwan; Jerry J Shih; David Squillacote; Haichen Yang; Michelle Gee; Jin Zhu; Antonio Laurenza
Journal: Epilepsia Date: 2012-08-20 Impact factor: 5.864

4. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.

Authors: Jacqueline A French; Gregory L Krauss; Bernhard J Steinhoff; David Squillacote; Haichen Yang; Dinesh Kumar; Antonio Laurenza
Journal: Epilepsia Date: 2012-08-20 Impact factor: 5.864

5. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.

Authors: Bernhard J Steinhoff; Elinor Ben-Menachem; Philippe Ryvlin; Simon Shorvon; Lynn Kramer; Andrew Satlin; David Squillacote; Haichen Yang; Jin Zhu; Antonio Laurenza
Journal: Epilepsia Date: 2013-05-10 Impact factor: 5.864

Review 6. A systematic review of the risks factors associated with the onset and natural progression of epilepsy.

Authors: Stephanie Walsh; Jennifer Donnan; Yannick Fortin; Lindsey Sikora; Andrea Morrissey; Kayla Collins; Don MacDonald
Journal: Neurotoxicology Date: 2016-03-19 Impact factor: 4.294

7. QuickStats: Age-Adjusted Percentages* of Adults Aged ≥18 Years Who Have Epilepsy, by Epilepsy Status(†) and Race/Ethnicity(§) - National Health Interview Survey, United States, 2010 and 2013 Combined(¶).

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2016-06-17 Impact factor: 17.586

8. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.

Authors: Jacqueline A French; Gregory L Krauss; Robert T Wechsler; Xue-Feng Wang; Bree DiVentura; Christian Brandt; Eugen Trinka; Terence J O'Brien; Antonio Laurenza; Anna Patten; Francesco Bibbiani
Journal: Neurology Date: 2015-09-15 Impact factor: 9.910

9. Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures.

Authors: Blanca Vazquez; Haichen Yang; Betsy Williams; Sharon Zhou; Antonio Laurenza
Journal: Epilepsia Date: 2015-06-11 Impact factor: 5.864

Review 10. Perampanel for focal epilepsy: insights from early clinical experience.

Authors: E Trinka; B J Steinhoff; M Nikanorova; M J Brodie
Journal: Acta Neurol Scand Date: 2015-10-28 Impact factor: 3.209

14 in total

1. Discovery of Imidazo[1,2-a]pyrazines and Pyrazolo[1,5-c]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators.

Authors: Brad M Savall; Dongpei Wu; Devin M Swanson; Mark Seierstad; Nyantsz Wu; Jorge Vives Martinez; Beatriz García Olmos; Brian Lord; Kevin Coe; Tatiana Koudriakova; Timothy W Lovenberg; Nicholas I Carruthers; Michael P Maher; Michael K Ameriks
Journal: ACS Med Chem Lett Date: 2018-12-26 Impact factor: 4.345

2. Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8.

Authors: Suchitra Ravula; Brad M Savall; Nyantsz Wu; Brian Lord; Kevin Coe; Kai Wang; Mark Seierstad; Devin M Swanson; Jeannie Ziff; Minh Nguyen; Perry Leung; Ray Rynberg; David La; Daniel J Pippel; Tatiana Koudriakova; Timothy W Lovenberg; Nicholas I Carruthers; Michael P Maher; Michael K Ameriks
Journal: ACS Med Chem Lett Date: 2018-07-13 Impact factor: 4.345

Review 3. Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors: Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal: Pharmacol Rev Date: 2021-10 Impact factor: 18.923

4. Differential acute impact of therapeutically effective and overdose concentrations of lithium on human neuronal single cell and network function.

Authors: Julia Izsak; Henrik Seth; Margarita Iljin; Stephan Theiss; Hans Ågren; Keiko Funa; Ludwig Aigner; Eric Hanse; Sebastian Illes
Journal: Transl Psychiatry Date: 2021-05-12 Impact factor: 6.222

Review 5. Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy.

Authors: Michele A Faulkner
Journal: Drug Des Devel Ther Date: 2017-10-04 Impact factor: 4.162

6. Preliminary Asian experience of using perampanel in clinical practice.

Authors: Hsing-I Chiang; Siew-Na Lim; Hsiang-Yao Hsieh; Mei-Yun Cheng; Chun-Wei Chang; Wei-En Johnny Tseng; Han-Tao Li; Chin-Yin Lin; Tony Wu
Journal: Biomed J Date: 2018-02-03 Impact factor: 4.910

7. Clinical outcomes of two patients with a novel pathogenic variant in ASNS: response to asparagine supplementation and review of the literature.

Authors: Rosanne Sprute; Didem Ardicli; Kader Karli Oguz; Anna Malenica-Mandel; Hülya-Sevcan Daimagüler; Anne Koy; Turgay Coskun; Haicui Wang; Meral Topcu; Sebahattin Cirak
Journal: Hum Genome Var Date: 2019-05-22